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Coded by a single gene (Slo1, KCM) and activated by depolarizing potentials and by a rise
in intracellular Ca2+ concentration, the large conductance voltage- and Ca2+-activated K+
channel (BK) is unique among the superfamily of K+ channels. BK channels are tetramers
characterized by a pore-forming α subunit containing seven transmembrane segments
(instead of the six found in voltage-dependent K+ channels) and a large C terminus
composed of two regulators of K+ conductance domains (RCK domains), where the
Ca2+-binding sites reside. BK channels can be associated with accessory β subunits and,
although different BK modulatory mechanisms have been described, greater interest has
recently been placed on the role that the β subunits may play in the modulation of BK
channel gating due to its physiological importance. Four β subunits have currently been
identified (i.e., β1, β2, β3, and β4) and despite the fact that they all share the same
topology, it has been shown that every β subunit has a specific tissue distribution and that
they modify channel kinetics as well as their pharmacological properties and the apparent
Ca2+ sensitivity of the α subunit in different ways. Additionally, different studies have
shown that natural, endogenous, and synthetic compounds can modulate BK channels
through β subunits. Considering the importance of these channels in different pathological
conditions, such as hypertension and neurological disorders, this review focuses on
the mechanisms by which these compounds modulate the biophysical properties of BK
channels through the regulation of β subunits, as well as their potential therapeutic uses
for diseases such as those mentioned above.
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INTRODUCTION
Consisting of 5 families and more than 70 different encoding
genes inmammals, the diversity of K+ channels is amazingly large
(for a comprehensive review on K+ channels, see González et al.,
2012). In particular, the Ca2+- and voltage-activated K+ (BK)
channel is a relative of the 6-transmembrane domain voltage-
dependent K+ (Kv) channel family, which is also part of the
S4 superfamily encompassing voltage-dependent Na+ and Ca2+
channels. There are, however, several differences between Kv and
BK channels that make BK channels unique. First, BK channels
are encoded by a single gene (Slo1). Second, they contain seven
transmembrane domains and, hence, the N-terminus is in contact
with the cell external milieu (Meera et al., 1997) (Figure 1). Third,
the BK channel can be independently activated by Ca2+ or volt-
age, and it can open in the absence of Ca2+. Moreover, it is clear
at present that voltage and Ca2+ sensors are allosterically coupled
to channel opening (as reviewed in Latorre et al., 2010; Horrigan,
2012). In other words, voltage or Ca2+ alone can open the chan-
nel, but the free energy required to open the channel greatly
decreases when both sensors are activated. Finally, unlike Kv
channels, wheremost voltage-sensing charges are contained in the
S4 transmembrane segment, only about 50% of the gating charges
for BK channels are in S4 and the rest of the voltage-sensing
particles reside in S3 and S2 (Ma et al., 2006). Accordingly, the BK
voltage sensor can be defined as a decentralized voltage sensor.
The BK channel in mammals is ubiquitously distributed in dif-
ferent tissues and, because it is activated by voltage and Ca2+,
it is the perfect molecular machine to reduce or stop excitatory
stimuli. For example, the BK channel modulates neurotransmit-
ter release by co-localizing with voltage-dependent Ca2+ channels
(Robitaille and Charlton, 1992). In vascular smooth muscle cells,
BK channels regulate contractile tone. In this case, increments
in local Ca2+ (i.e., Ca2+ sparks) produce BK channel-mediated
spontaneous transient outward currents (STOCs), thus hyperpo-
larizing the membrane and producing muscle relaxation (Jaggar
et al., 2000; Ledoux et al., 2006). On the other hand, alterations in
BK channels are known to be important in the pathophysiology
of hypertension, asthma, diabetes, and epilepsy (as reviewed in
Contreras et al., 2013). Because of the profound involvement of
BK channels in the health problems described above, their acti-
vators, and blockers have potential therapeutic implications. In
several cases, the action of these compounds is mediated by their
binding to the β subunit or modulated by the presence of these
subunits. Hence, the main goal of the present review is to provide
an overview of our current knowledge of how suchmediation and
modulation are accomplished.
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FIGURE 1 | Topological representation of the human Calcium-activated potassium channel α subunit. Using Protter visualizator (Omasits et al., 2014),
UniProt protein accession: Q12791.
BK CHANNEL β SUBUNITS
In most tissues, the BK channel is associated with accessory β
subunits. To date, four β subunits (β1–β4, encoded by the genes
KCNMB1–4) have been identified (Figure 2) and their expres-
sion depends on cell type (as reviewed in Contreras et al., 2013)
(Table 1). All β subunits share the same predicted structural char-
acteristics (170–200 residues in length) and they are composed of
two transmembrane segments (i.e., TM1 and TM2), intracellu-
lar N and C termini and a large extracellular loop (as reviewed
in Orio et al., 2002; Torres et al., 2007; Hoshi et al., 2013b). The
first β subunit to be identified was β1 in tracheal smooth muscle
cells (Figure 3A) (Garcia-Calvo et al., 1994; Knaus et al., 1994).
In heterologous systems such as Xenopus oocytes and cell cultures,
the co-expression of β1 with the α subunit leads to an increase in
the apparent Ca2+ sensitivity of the channel, which slows down
activation and deactivation kinetics and causes a lefward shift in
G-V relations by −70 to −80mV at 5–10μM intracellular Ca2+
concentrations (McManus et al., 1995; Wallner et al., 1995; Meera
et al., 1996; Tanaka et al., 1997; Brenner et al., 2000a; Cox and
Aldrich, 2000; Nimigean and Maglebly, 2000; Bao and Cox, 2005;
Orio and Latorre, 2005).
Functional coupling between α and β1 subunits is determined
by the S0 transmembrane segment of the BK channel. Cysteine
crosslinking experiments have indicated that β1 lies between and
can interact with the voltage sensors of two adjacent α subunits,
and that TM2 lies in the proximity of S0 (Wallner et al., 1996; Liu
et al., 2010). Similar to the β1 subunit, β2 also increases appar-
ent BK channel Ca2+ sensitivity and alters its gating kinetics, but
the existence of 31 more amino acid residues in the N termi-
nal has shown to promote an inactivation process (Figure 3B)
(Wallner et al., 1999; Brenner et al., 2000a; Xia et al., 2003; Orio
and Latorre, 2005). Although it behaves as an open channel block
(Wallner et al., 1999), this N-type inactivation does not promote
charge inmobilization, as in the N-type inactivation observed
in Shaker K+ channels (Savalli et al., 2007). It is important to
mention that although the β1 subunit can exist in a 1:1 stoi-
chiometry with α subunits, there is a report suggesting that the
variability seen in BK inactivation behavior in rat chromaffin cells
can originate from a less than a 1:1 assembly of β2 and α subunits
(Knaus et al., 1994; Ding et al., 1998; Wang et al., 2002).
The β3 subunit is less similar to the β1 and β2 subunits
(Figure 3C) and confers distinct modulating characteristics to the
α subunit (Riazi et al., 1999; Xia et al., 2000). There are four dif-
ferent β3 subunits (β3a–d), which all originate from alternative
splicing of the same gene (i.e., KCNMB3) (Brenner et al., 2000b;
Uebele et al., 2000). It was reported that TM1 is closest to αS1 and
S2 and TM2 is closest to αS0 (Wu et al., 2013). The expression
of β3a, b, and c causes a partial inactivation of potassium cur-
rents. Althoug β3a and c induce a similar inactivation process as
the β2 subunit, β3b-dependent inactivation is faster. The β3d sub-
unit does not causes inactivation of potassium currents (Brenner
et al., 2000b; Uebele et al., 2000).
Similar to β1, TM1 from β4 subunit is nearest to αS1 and
S2 meanwhile β4 TM2 is closest to S0 (Wu et al., 2009). This
subunit its expressed in the brain and is considered to be a
downregulator of BK channels by dramatically decelerating BK
channel activation gating kinetics (Figure 3D) (Weiger et al.,
2000). However, although β4 shifts conductance-voltage curves
to the right along the voltage axis at Ca2+ concentrations lower
that 1μM, it increases apparent Ca2+ sensitivity at Ca2+ concen-
trations larger than 1μM (Brenner et al., 2000b; Ha et al., 2004;
Wang et al., 2006). Additionally, the β4 subunit reduces the volt-
age dependence of the conductance–voltage relationship as well
as the slope of the gating charge-voltage curve (Wang et al., 2006;
Contreras et al., 2012).
THE ROLE OF β SUBUNITS IN BK CHANNEL
PHARMACOLOGY
BK channels can be modulated by diverse molecules that may
induce either an increase or decrease in channel activity. The
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FIGURE 2 | Human calcium-activated potassium channel β subunit alignment. Using MUSCLE software (Edgar, 2004). UniProt protein accession: KCMB1,
Q16558; KCMB2, Q9Y691; KCMB3, Q9NPA1; KCMB4, Q86W47.
Table 1 | Tissue expression of the BK channel accessory β subunits.
Subunit Chromosome
location (human)
Gene symbol
(human)
UniProt protein accession
number (human)
Tissue expression
β1 5q34 KCNMB1 Q16558 Smooth muscle (Knaus et al., 1994), kidney, urinary bladder (Wu and
Marx, 2010), brain (Tseng-Crank et al., 1996), myometrium (Wallner
et al., 1996)
β2 3q26.32 KCNMB2 Q9Y691 Pancreas (Ohya et al., 2010), kidney, (Uebele et al., 2000), chromafin
cells (Xia et al., 1999), brain (Wallner et al., 1999)
β3a 3q26.3-q27 KCNMB3 Q9NPA1-2 Spleen, placenta, pancreas, heart, kidney (Behrens et al., 2000;
Brenner et al., 2000b; Uebele et al., 2000; Xia et al., 2000)
β3b 3q26.3-q27 KCNMB3 Q9NPA1-4 Lung, liver, testes, spleen, placenta, pancreas, heart, kidney, brain
(Behrens et al., 2000; Brenner et al., 2000b; Xia et al., 2000)
β3c 3q26.3-q27 KCNMB3 Q9NPA1-3 Ovary, brain, lung, liver, spleen, placenta, pancreas, prostate, kidney
(Behrens et al., 2000; Brenner et al., 2000b; Xia et al., 2000)
β3d 3q26.3-q27 KCNMB3 Q9NPA1-1 Lung, brain, testes, spleen, placenta, pancreas, kidney (Behrens
et al., 2000; Brenner et al., 2000b; Xia et al., 2000)
β4 12q KCNMB4 Q86W47 Brain, neuronal tissue, Behrens et al., 2000; Brenner et al., 2000b
kidney, bladder smooth muscle (Chen and Petkov, 2009)
effects of these molecules can be exerted through direct interac-
tions with the α subunit and, in some cases, by the expression
of β subunits, which would modify such effects. Nevertheless,
some of these molecules need β subunits to modulate BK chan-
nel activity. The effects of various molecules that have been
extensively studied as BK channel modulators and whose activ-
ity has been proposed to be related to β subunit expression
will be described here (Table 2). Among the latter, toxins (such
as charybdotoxin, iberiotoxin), ethanol, steroids, and fatty acids
(like araquidonic acid and metabolites) are also mentioned.
Molecules like tungstate, DiBAC4(bis (1,3-dibutylbarbituric acid)
trimethine oxonol), nitric oxide (NO) and tetrandrine, whose
effects are determined by β subunits and have not been studied
in detail will be also described.
TOXIN INTERACTION
BK channels have been described to be sensitive to scorpion-
peptide toxins, such as charybdotoxin (ChTX), iberiotoxin
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FIGURE 3 | Topological representation of human Calcium-activated potassium channel β subunits. Using Protter visualizator (Omasits et al., 2014).
UniProt protein accession: (A) KCMB1: Q16558, (B) KCMB2: Q9Y691, (C) KCMB3: Q9NPA1, (D) KCMB4: Q86W47.
(IbTX), slotoxin (SloTX), and martentoxin (Figure 4). Toxins
can affect channel properties with different affinities and speci-
ficities, and their binding has been shown to be modulated
by the coexpression of β subunits. For example, while IbTX—
which is a 37 amino acid peptide present in the venom of
the African scorpion Buthus tamulus (Galvez et al., 1990)—is
a specific BK channel blocker (Kaczorowski and Garcia, 1999),
ChTX—which is a peptide with the same number of amino
acid residues isolated from the scorpion Liurus quinquestriatus—
blocks other potassium channels (Galvez et al., 1990; Kaczorowski
and Garcia, 1999). Interestingly, both toxins reversibly block BK
channels by externally binding to the mouth of the channel
through a bimolecular reaction (Miller et al., 1985; Anderson
et al., 1988; Candia et al., 1992; Giangiacomo et al., 1992).
IbTX and ChTX blockade is characterized by long-lived (blocked)
non-conducting states that separate bursts of activity. These long-
lived blocked states define mean blocked times of 10 and 200 s
for ChTX and IbTX, respectively. Under similar experimental
conditions, the dissociation constant (Kd ∼1.5 nM) for IbTX
is nearly 10-fold smaller than for ChTX (Candia et al., 1992;
Giangiacomo et al., 1992; Gribkoff et al., 1996; Mullmann et al.,
1999).
It has been shown that ChTX and IbTX toxins have different
net charges that may affect selectivity by means of a mechanism
involving electrostatic interactions with BK channels. Since the
channel external vestibule has a fixed negative charge density
region, a local electrostatic potential is set up near the toxin bind-
ing site, raising the local concentration of the positively-charged
toxin (Anderson et al., 1988). Although ChTX and IbTX are
equal in size and display a highly homologous sequence (68%
homologous), ChTX has a net charge of +5 due to the pres-
ence of several basic residues, while the net charge for IbTX
is +2, since it has 4 more acidic residues and 1 basic amino acid
residue less than the ChTX (Figure 5). The latter would explain
the different behaviors observed in their toxin-channel electro-
static interactions where the binding of ChTX to BK channel
is more sensitive to ion strength variations that IbTX binding
(Galvez et al., 1990; Candia et al., 1992; Giangiacomo et al.,
1992). Additionally, it has been suggested that an electrostatic
mechanism underlies the dissociation of ChTX from the chan-
nel (Anderson et al., 1988; MacKinnon and Miller, 1988). The
apparent voltage dependence of the channel block is due to a
destabilization of the channel-toxin complex, which is mediated
by K+ ions entering the selectivity filter from the internal side
when the membrane is depolarized, hence inducing a repulsion
force that unbounds the toxin from the channel (MacKinnon and
Miller, 1988).
These two toxins plug the BK channel by means of direct inter-
action between toxin lysine 27 and the channel selectivity filter
(Park andMiller, 1992; Mullmann et al., 1999). The above studies
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Table 2 | Molecules that regulate BK channel activity through β
subunits.
Ligand Subunit associated to a
modulatory effect on the BK
channel activity
Toxins Charybdotoxin β1, β2, β3, and β4
Iberiotoxin β1 and β4
Slotoxin β1 and β4
Martentoxin β4
Vt 3.1 β4
Fatty acids Arachidonic acid β1, β2, and β3
Docosahexaenoic β1 and β4
Eicosapentaenoic β1
Acil-CoA β2
Alcohol Ethanol β1 and β4
Steroids 17β-Estradiol β1
Tamoxifen β1
Dehydroepiandrosterone β2 and β4
Lithocolic acid β1
Dehydrosoyasaponin-I β1
Others Tungstate β1
DiBAC4 β1, β2, and β4
led to the hypothesis that lysine 27 seems to be in the proximity of
one of the external K+ binding sites. This hypothesis has recently
been fully confirmed by Banerjee et al. (2013), who were able to
solve the crystal structure of the chimeric channel Kv1.2/Kv2.1
in complex with ChTX. The structure of the Kv-ChTX complex
shows that the toxin binds to the extracellular aspect of the selec-
tivity filter and the most extracellular K+ binding site is devoid of
K+ ions.
Coexpression of BK channel α and β subunits causes a dra-
matic effect on ChTX-BK interaction properties when compared
to the α subunit alone. It has been suggested that extracellular
loop from β subunit is involved in the formation of the toxin
receptor (Hanner et al., 1997). The affinity of ChTX to α +β1
channels is 50-fold larger than that of channels formed by the
α subunit alone. This increase in toxin binding potency is due
to a seven-fold decrease in the toxin dissociation rate constant
and an increase of about five-fold in the association rate con-
stant (Hanner et al., 1997). To identify the β1 subunit amino acid
residues involved in ChTX binding affinity changes, an alanine
scanning mutagenesis along the β1 external loop was performed.
The results indicated that the L90, Y91,W93, and E94 residues are
critical for ChTX high-affinity binding to the α + β1 BK chan-
nel. Mutations to alanine of these residues do not change the
physical interactions between β1 and α subunits. However, they
affect ChTX association and dissociation kinetics, suggesting that
the mutated residues may be significantly involved in the large
increases observed in ChTX binding affinity in the presence of
the β1 subunit (Hanner et al., 1998).
It is worthy of noting that studies have shown that BK channels
expressing auxiliary subunits other than β1 change their affinity
FIGURE 4 | Toxin structure. (A) Charybdotoxin: PDB ID 2CRD; (Bontems
et al., 1992). (B) Martentoxin: PDB ID 1M2S (Wang et al., 2005). (C)
Iberiotoxin: PubChem ID 16132435. (D) Slotoxin: PubChem ID 16133816.
Using PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LL.
Green: carbon atoms, white: hydrogen atoms, red: oxygen atoms, blue:
nitrogen atoms, yellow: sulfur atoms.
to toxins in an opposite way, that is, by inducing a decrease in
the toxin association rate. For instance, Reinhart et al. (1989)
describe channels with two different sensitivities to ChTX in
brain neurons, namely that while one type of BK channel was
blocked with concentrations similar to those required to block
the BK channel from skeletal muscle membranes, as describe by
Anderson et al. (1988), the others were rather insensitive to the
toxin. Further studies on rat supraoptic magnocellular neurons
reported by Dopico et al. (1999b) showed similar results, where
some BK channels were blocked at ChTX or IbTX concentra-
tions of 10 nM, while the others were insensitive to ChTX even
at concentrations as large as 360 nM. To explain such differences
in sensitivity, Meera et al. (2000) reported that coexpression of
α with the β4 subunit (which is the β subunit present in the
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FIGURE 5 | Sequence alignment of the ChTX family of K+ toxins. Using MUSCLE software (Edgar, 2004). UniProt protein accession: Charybdotoxin,
P13487; Iberiotoxin, P24663; Slotoxin, P0C182; Martentoxin, Q9NBG9.
brain) leads to a BK channel phenotype that displays very low
ChTX and IbTX sensitivity. Meera et al. (2000) proposed that
the molecular basis for toxin insensitivity in BK channels found
in neurons is that they are formed by the α + β4 subunit com-
bination (Behrens et al., 2000; Meera et al., 2000). β4 subunit
expression induces a rise in the apparent half-maximal inhibitory
concentration (IC50) of the BK channel and a lessening of the
toxin association rate by 250–1000-fold. To explain the mecha-
nism that may determine the differences in effects induced by
the β1 and β4 subunits on ChTX binding to BK channels, the
smooth muscle β1 subunit extracellular loop was exchanged with
the neuronal β4 subunit loop. The results showed that the β sub-
unit extracellular loop determined the affinity of this toxin to
the BK channel. The β4 subunit external loop contains more
basic residues (e.g., K120, R121, K125) than the β1 subunits,
and their neutralization, or charge reversals (i.e., R121D) greatly
increase toxin association and dissociation rates. These results
suggest that positively charged residues impose an electrostatic
shield on ChTX action (Gan et al., 2008). When comparing β1
and β4 subunits, it has been shown that β4 is missing a con-
served Y100 residue, and restoring this residue into the β4 subunit
enables the recovery of the α + β4 BK channel’s higher sensi-
tivity to ChTX. In addition, tyrosine 294 at the C-terminal end
of the pore loop in mslo, which interacts with Y36 in ChTX,
as well as the missing β4 Y100 residue are possible sites for
ChTX channel interaction (Gao and Garcia, 2003; Gan et al.,
2008).
These results have also been confirmed by studies evaluating
IbTX affinity to BK channels, where the presence of β4 leads to
reduced toxin binding to the channels. However, unlike ChTX,
the presence of β1 decreases IbTX association rates by about 40-
fold and produces a large decrease (∼100-fold) in dissociation
rates. The end result of this is that although α + β1 BK channels
show less sensitivity to IbTX, binding is essentially irreversible
(Meera et al., 2000). These results strongly suggest that differ-
ences in toxin residues determine combinatorial effects with the
extracellular loop of the β subunit. However, it is important to
consider that some reports have found that IbTX behaves similar
to ChTX in the presence of β1. This discrepancy can be due to
differences in the ionic strengths of the solutions used to perform
the experiments (Hanner et al., 1997; Meera et al., 2000).
Similar to the effects observed in channels expressing α + β4
subunits, the expression of β2 was found to trigger a steeper
decrease in response rates to ChTX compared to the effect on the
α subunit alone [EC50 = 58 nM and 1 nM, respectively] (Wallner
et al., 1999). This has been further corroborated in chromaf-
fin cells, where the β2 subunit is endogenously expressed (Ding
et al., 1998). Additionally, studies evaluating the coexpression of
α + β3 channels also report a decrease in the degrees of block-
ade by ChTX (IC50 80 nM) (Xia et al., 1999, 2000; Zeng et al.,
2008), together with a change in the magnitude and kinetics of
the blocking reaction (Ding et al., 1998). Different to what has
been found when comparing amino acid sequences of β1 and
β4, residues proposed to mediate ChTX interaction with β1 are
present in the β3 subunit, which suggests that other differences
between both subunits are responsible for dissimilarities in ChTX
sensitivity (Xia et al., 1999).
Although the previous results strongly suggest that amino
acid sequences in the β subunit and toxin loop play an impor-
tant role in toxin affinity to the BK channel, IbTX, and ChTX
surface charge interfaces have been found to be nearly identi-
cal. This means that peptide net charge does not contribute to
their potassium channel specificities, suggesting that the molec-
ular mechanism responsible for such effects would be related to
glycosylations in the β subunit extracellular loop and its proximity
to the channel vestibule (Gao and Garcia, 2003).
Another scorpion toxin from the Centruroides noxius species
that specifically inhibits mammalian BK channels is Slotoxin
(SloTX), which has 76% of identity to IbTX and 54% to ChTX
(Garcia-Valdes et al., 2001). Like IbTX and ChTX, SloTX inter-
acts through a bimolecular reaction by blocking BK α subunit
pore domain. In addition, the toxin can differentiate between
the channels expressing α, α + β1, and α + β4 subunits. If the
β1 subunit is coexpressed with the α subunit, on-rates of chan-
nel blockade are reduced by two orders of magnitude com-
pared to when the BK channel α subunit is alone. Furthermore,
off-rates acutely decrease, making SloTX blockade irreversible.
Toxin association rates in oocytes coexpressing α + β4 subunits
are much slower than when β1 is present. Therefore, α + β4
channels are extremely resistant to SloTX blockade, but once
blocked, toxin interaction seems irreversible (Garcia-Valdes et al.,
2001).
Frontiers in Physiology | Membrane Physiology and Membrane Biophysics October 2014 | Volume 5 | Article 383 | 6
Torres et al. BK channel β subunit pharmacology
Martentoxin, which is a peptide isolated from Buthus martensi
Karsch scorpion venom, can bind to K+ channels by means of a
similar mechanism as other well-known scorpion toxins (Ji et al.,
2003; reviewed in Tao et al., 2012). Martentoxin preferentially
selects BK over Kv channels with a 1000-fold difference (Shi et al.,
2008). After blocking BK channel currents with martentoxin, full
recovery is achieved much faster than with ChTX (Ji et al., 2003).
Martentoxin is a unique neurotoxin whose activity depends on
Ca2+ concentrations, and which selectively blocks α + β4 subunit
BK channels with a higher preference than channels expressing
the α subunit alone (Shi et al., 2008; Tao et al., 2014). At low
Ca2+ cytoplasmic concentrations, neuronal α + β4 BK channel
currents are inhibited by martentoxin, but at high Ca2+ concen-
trations the toxin acts as an agonist. Martentoxin does not shift
BK channel (α + β1) conductance-voltage dependence, thus indi-
cating that this toxin does not interact with the voltage sensor,
unlike β1 (Tao et al., 2011). After applying 400 nM of marten-
toxin, the current induced by αBK channels by a +80mV pulse
was not significantly affected, despite the fact that 400 nM of IbTX
abolishes it completely (Shi et al., 2008). This result suggests that
BK channels expressing only α subunits are insensitive to mar-
tentoxin, which could make it a potential selector for BK channel
subtypes (Tao et al., 2011).
The toxin Vt3.1 is a disulfide-cross-linked dimer conopeptide
isolated from Conus vitulinus that acts on BK channels activity by
a different mechanism of that reported for toxins like ChTX and
IbTX. Toxin Vt3.1 inhibits α BK channels. However, its effect is
substantially enhanced when channels are formed by α + β4. This
property makes the Vt3.1 toxin an excellent tool for the study of
neuronal BK channels where the β4 subunit is highly expressed (Li
et al., 2014). Li et al. (2014) have suggested that this toxin affects
the gating mechanism of the channel and induces a shift in G-V
relation to more positive voltages.
FATTY ACIDS
The well-known role of BK channels in the regulation of vas-
cular tone and their high expression in neurons have increased
current interest in evaluating the effects of cardiovascular and
nervous system regulators (such as fatty acids) on the biophysical
properties of BK channels. For instance, BK channel activa-
tion by epoxyeicosatrienoic acids (EET), which are arachidonic
acid metabolites, has been observed to result in concentration-
dependent coronary artery relaxation (Eckman et al., 1998).
Recent studies have found that unsaturated cis fatty acids,
such as palmitoleic (PAM), oleic (OA), linoleic (LA), linolenic
(ALA), arachidonic (AA), and eicosapentaenoic acids (EPA)
(Figures 6A–F), significantly heighten BK channel activity by
increasing their open probability (P0) without affecting chan-
nel voltage sensitivity or unitary conductance (Ahn et al.,
1994; Denson et al., 2000; Clarke et al., 2002; Zheng et al.,
2005). However, saturated and trans-unsaturated fatty acids
have no effect on channel activity. In addition, it has been
demonstrated that AAmetabolites, such as 11,12-EET, and 14,15-
EET (Figures 6G,H), increase BK channel P0 in cells from both
pig coronary arteries and rat pituitary GH3 with no effect on
their unitary conductance and Ca2+ sensitivity, hence providing
evidence for the direct influence of EET on the channel protein
(Baron et al., 1997; Wu et al., 2000a). This was further corrobo-
rated by using inhibitors such as ChTX and TEA, which diminish
or abolish the effects induced by EET on P0 in bovine coronary
arterial smooth muscle cells (Campbell et al., 1996). On the other
hand, results observed by Fukao et al. (2001) suggest that 11,
12-EET directly acts on the α subunit independently from the
β-subunit. The role of the α subunit complex as a high affinity
receptor for fatty acids has been confirmed with docosahexaenoic
acid (DHA), which activates BK channels from excised patches
in a reversible way (Hoshi et al., 2013a). Recent studies using
human BK mutants (Y318S) showed a significant decrease in the
amplifying effect of DHA (Figure 6I) and EPA currents, suggest-
ing that this residue located in the S6 segment is either part of
the fatty acid binding site or constitutes an important piece of
the coupling system that transforms chemical binding energy into
pore-opening energy (Hoshi et al., 2013a). However, no changes
were observed when AA or ALA was used (Hoshi et al., 2013c),
indicating that additional α subunit residues or auxiliary subunits
may be required for the enhancing effects of these fatty acids on
BK channels.
In order to increase BK channel activity, studies thus far have
shown that fatty acids must have the following molecular charac-
teristics: more than 8 carbon atoms, one ormore cis unsaturations
and a negative charge (Ahn et al., 1994; Denson et al., 2000; Zheng
et al., 2005). Neutral and short-chain lipids have no effect on
P0, while positively charged lipids (like sphingosine) produced a
decrease in NP0. Increases in P0 result from decreases in mean
closed time (τc) without modifying mean open time (τo) (Clarke
et al., 2002, 2003).
Similar to the differential effects seen from toxins in the pres-
ence of auxiliary subunits, the effects of fatty acids on BK channels
are modified by β subunit expression where fatty acids interacts
directly with β subunits (Martín et al., 2013). When examining
AA effects on BK channels formed by α + β2 or α + β3 subunits,
a potentiation in the current and a slowdown in inactivation
(α + β2 channels) were displayed. It is thought that this effect
could be mediated by the direct interaction of AA with the chan-
nel rather than through its metabolites (Sun et al., 2007). When
BK channels are modulated by AA, β subunits have important
implications for the adequate function of the nervous system,
considering that the expression of β2 and β3 are specific to certain
types of neurons. In the absence of β2 or β3 or in the presence
of β4, AA does not induce a significant response to BK chan-
nels. Furthermore, AA causes an increase in P0 as well as in the
number of open channels. Effects on peak current amplitude
and α + β2 current inactivation kinetics have been observed to
be dose-dependent in the range of 1–50μM of AA. At higher
AA doses, a complete loss of the inactivation component was
evident. Data supports the premise that the effects of AA are
mediated by changes in trypsin-sensitive inactivation and that
there is no obvious fatty acid-mediated activation effect upon
removing inactivation. As a whole, the β2-dependent BK channel
inactivation gate is a specific molecular target for AA and other
unsaturated fatty acids (Sun et al., 2007). In addition, it has been
shown that DHA and oleic acid (OA) can also activate α + β2
current and slow down inactivation kinetics, whereas saturated
fatty acids (i.e., palmitic, stearic, and caprylic acid) seem to have
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FIGURE 6 | Chemical structure of unsaturated fatty acids that
modulate BK channel activity. (A) PAM, Palmitoleic Acid; (B) OA, Oleic
Acid; (C) LA, Linoleic Acid; (D) ALA, Linolenic Acid; (E) AA, Arachidonic
Acid; (F) EPA, Eicosapentaenoic Acid; (G) DHA, Docosahexaenoic acid;
(H) 11, 12 EET, 11, 12 Epoxyeicosatrienoic acid; (I) 14, 15 EET, 14, 15
Epoxyeicosatrienoic acid. Using PyMOL Molecular Graphics System,
Version 1.5.0.4 Schrödinger, LL. Green, carbon atoms; white, hydrogen
atoms; red, oxygen atoms.
no effects. Of all the fatty acids tested, OA is the most potent in
enhancing BK currents.
In native human vascular smooth muscle cells, where the
β1 subunit is expressed, single channel recordings have shown
an important rise in the P0 of BK channels induced by AA
acid (Martín et al., 2013). In addition, AA accelerates voltage-
dependent activation kinetics of channel. Studies in HEK 293T
cells have concluded that β1 subunit expression is needed for AA
to activate the channel, since no effect has been seen when the β1
subunit is not expressed. Therefore, the β1 subunit is required to
mediate AA effects on BK channels by a mechanism that involves
modifying gating ring operation independently from channel
voltage sensitivity changes (Martín et al., 2013). In conclusion,
these results strongly suggest that BK channel activation by AA
requires the expression of β1, β2, or β3 subunits. Although such
mechanisms have not yet been fully established, Martín et al.
(2013) have suggested a mechanism for AA action that involves
an increase in P0, while Sun et al. (2007) have proposed that
AA prevents inactivation when BK channels are formed by the
α + β2 subunit.
The degree of DHA modulation, on the other hand, depends
on which β subunit is associated with the α subunit. For instance,
when β1 or β4 are expressed, a large increase in peak current can
be observed, but in α + β2 or αBK channels the response is rather
limited. In addition, DHA differentially influences activation or
deactivation kinetics, depending on which β subunit is present
(β1, β2, and β4) (Hoshi et al., 2013c). It has been reported that
DHA and EPA activate BK channels expressing β1 subunits (Lai
et al., 2009; Hoshi et al., 2013c), and DHA has a∼20-fold current-
enhancing effect on channels expressing α + β1. This effect is
associated with a leftward shift in half-activation voltage, which
also destabilizes the closed conformation of the conduction gate
and decreases the activation time constant. The following two
important residues determine the modulatory effects exerted by
DHA in β1 and β4 subunits: one residue is in the N terminus
(R11 in β1 and E12 in β4) and the other in TM1 (C18 in β1
and R19 in β4). The exchange of these residues with the equiv-
alent amino acids in β2 allows this subunit (as is the case of β1
and β4) to behave as an enhancer of the DHA effect (Hoshi et al.,
2013c).
In contrast to the enhancing effect found from fatty acids, a
metabolic intermediary in the synthesis of fatty acids (i.e., acyl-
CoA) has been shown to interact with the β2 subunit in inhibiting
BK currents (Sun et al., 2008). In cerebral ischemic damage,
selective AA reincorporation and accumulation into brain mem-
branes has been observed (Rabin et al., 1997). In addition, it is
acknowledged from studies in animal models that BK channel
activation can potentially protect neurons under ischemic con-
ditions (Rabin et al., 1997; Gribkoff et al., 2001). Moreover, the
effects of unsaturated fatty acids on BK channel activity may
influence neuronal survival/death, as their concentration may
undergo rapid changes under certain pathophysiological condi-
tions (Sun et al., 2007). Therefore, BK channel modulation by
acyl-CoA or unsaturated fatty acids may control events lead-
ing to cell protection or cell death. Understanding the role of
lipids under ion channel modulation conditions may lead to new
therapeutic uses (Sun et al., 2008).
ETHANOL
Ethanol is a well-known modulator of the BK channel activity, as
it has been described for several cells types such as neurons from
rat dorsal root ganglia, nucleus accumbens and neurohypohysial
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nerve terminals (reviewed in Dopico et al., 1999a; Gruss et al.,
2001; Knott et al., 2002; Martin et al., 2004). Changes in neu-
ropeptide release (Knott et al., 2002) and cerebrovascular tone
variations (Bukiya et al., 2009) are some of the reported effects
of ethanol, all of which are reversible and seen at clinically rel-
evant concentrations. It was initially proposed that such effects
were related to the number of functional channels, changes in
single channel conductance or modifications in gating proper-
ties. Subsequently, however, it was shown that gating properties
were modified by the direct binding of ethanol to BK channels
and by the activation of intracellular signaling cascades that may
regulate the channel (Dopico et al., 1996). More recently two
reports have described BK amino acid residues required for acti-
vation (Bukiya et al., 2014; Davis et al., 2014). The BK single-point
mutant T352I located in RCK1 was found to be utterly insensitive
to ethanol, with no changes in conductance, selectivity or gat-
ing (Davis et al., 2014). On the other hand, Bukiya et al. (2014)
unveiled an alcohol-sensing site, site that is only accessible to
ethanol in the presence of Ca2+. This site is located in the Ca2+-
sensing tail domain and molecular modeling suggest that residue
K361forms an essential hydrogen bond with ethanol only in the
presence of Ca2+.
Studies onmslo (Dopico et al., 1998; reviewed in Dopico et al.,
1999a), hslo (Feinberg-Zadek and Treistman, 2007; Feinberg-
Zadek et al., 2008) and bslo channels (Dopico, 2003) have shown
a concentration-dependent increase in NP0 related to gating
channel properties and not to changes in ionic conductance
(Dopico et al., 1996, 1998). BK channel response is known to be
voltage-independent, but is inextricably affected by intracellular
Ca2+ concentration changes. For instance, the potentiation of
mslo activity induced by ethanol decreases when intracellular
Ca2+ increases, meaning that BK channel activation by this
alcohol is more marked when intracellular Ca2+ is near basal
conditions (Dopico et al., 1996, 1999a). Effects on NP0 are
induced by a combination of increases in τ0 and decreases in τc
(Dopico et al., 1998).
It has also been observed that ethanol can increase BK chan-
nel activity in a tissue-dependent manner (Dopico et al., 1996,
1999b; Gruss et al., 2001; Knott et al., 2002), which was initially
related to BK isoforms and/or differential β subunit expression
in various tissues (Dopico, 2003). Of the cloned β subunits,
only β1, and β4 were studied and showed different responses.
In vascular smooth muscles, where the β1 subunit is predom-
inant (reviewed in Orio et al., 2002), ethanol effects depend
on intracellular Ca2+ concentrations (Bukiya et al., 2009). For
instance, when a BK channel-forming α-subunit isoform cloned
from rat cerebral artery myocytes (cbv1) is expressed in Xenopus
laevis, current potentiation after ethanol exposure (as seen by
decreases in V1/2) is evident at Ca2+ concentrations less than
20μM. On the other hand, rises in Ca2+ concentrations diminish
potentiation and concentrations’ over 30μM result in inhibi-
tion. The latter response denotes that basal Ca2+ concentrations
promote BK channel potentiation, whereas high concentrations
(>10μM) induce inhibition. Ethanol does not generate changes
in channel unitary current amplitude, which implies that its effect
on cbv1 channels is limited to modifying gating. Finally, the effect
of ethanol depends on the intracellular Ca2+ levels sensed by the
α subunit (Bukiya et al., 2009).
In studies, where cbv1 was co-expressed with the β1 subunit,
shifts from ethanol induced activation to inhibition were found
at Ca2+ concentrations less than 3μM. The latter implies that
β1 subunit expression induces BK channel current inhibition
by ethanol at intracellular Ca2+ levels similar to those reached
during cerebral myocyte contraction (4–30μM). These results
indicate that β1 subunit effect on ethanol activity is mediated
with an allosteric mechanism where β1 acts like a transducer
that couples changes in Ca2+ concentration to BK channel acti-
vation (Bukiya et al., 2009). Similar results were also found in
myocytes, indicating that the β1 subunit would be responsible for
ethanol-induced BK current inhibition at membrane potentials
and Ca2+ concentrations reached during cell contraction (Bukiya
et al., 2009).
In experiments performed on soma and dendrites of nucleus
accumbens neurons, BK channels exhibit a dual behavior, where
somatic channels are sensitive to ethanol, while dendritic chan-
nels are not. In other words, when the β4 subunit is expressed,
ethanol has a potentiating effect, whereas when β1 is expressed,
this effect is not exerted. These results were further confirmed by
heterologous expressions of α and β4 subunits in HEK293 cells
(Martin et al., 2004; Treistman and Martin, 2009). The increase
of the α + β4 channel’s NP0 results from a rise in τo and a fall in
τc (Feinberg-Zadek and Treistman, 2007).
The effect of β1 and β4 in the response of BK channels to
ethanol has been related to alcohol tolerance, implying a loss
of effectiveness with time, which is a key feature of addiction
(Martin et al., 2008). The mechanism by which β subunits deter-
mine BK channel potentiation seems to also modulate alcohol
sensitivity, whichmay contribute to explaining the roles of genetic
predisposition and tissue-dependent expression of BK channels
(Feinberg-Zadek and Treistman, 2007). For example, β1 deter-
mines low BK channel sensitivity to ethanol (Feinberg-Zadek
et al., 2008), whereas β4 subunit expression in BK channels poten-
tiates the response to ethanol. This suggests that in the absence of
the β4 subunit, acute tolerance of BK channels is induced, while
the presence of this subunit abolishes it. Accordingly, there is a
strong association between alcohol tolerance and predisposition
to alcoholism. Therefore, the β4 subunit could determine specific
differences related to alcohol abuse and alcoholism, hence making
it a potential therapeutic target (Martin et al., 2008). Intermittent
chronic alcohol exposure could increase expression of β1 subunits
in local brain regions. The latter could be used as a good strategy
in alcohol-dependent subjects to selectively alter their motiva-
tional drive to excessively consume alcohol (Kreifeldt et al., 2013).
STEROIDS
Steroids usually exert their action through specific receptors
within cells. The lipophilic nature of these components benefits
their entrance across the cellular membrane to the cytoplasm,
allowing them to bind to receptors acting as transcription factors
in the nucleus. (Thiede et al., 2012). Nevertheless, there are cer-
tain rapid effects that are independent of this nuclear signalization
and start in membrane receptors (Simoncini et al., 2004).
17β-estradiol (E2) (Figure 7A) has been shown to activate BK
channels in a nuclear receptor-independent manner. This activa-
tion is caracterized by an increase in potassium currents, acceler-
ated current kinetics and a rise in P0 to less positive potentials
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at 1–20μM of E2 and at low Ca+2 concentrations (∼100 nM)
(Valverde et al., 1999; De Wet et al., 2006). The observed incre-
ments in BK activity are related to the expression of auxiliary β
subunits, that can act like a receptor for E2 (King et al., 2006).
Such increments can be β1-dependent at <1μM of E2 or β1-,
β2-, and β4- dependent at 1–30μM, (Behrens et al., 2000; King
et al., 2006), which suggests the existence of an E2 membrane
receptor that can distinguish between different β subunits. (King
et al., 2006). The action of E2 on BK channels is determined by
type of β subunit expression, and it can be observed in native
(Holdiman et al., 2002; Coiret et al., 2005; Ohya et al., 2005),
and heterologous expression (Valverde et al., 1999; De Wet et al.,
2006).
Although E2 can activate the BK channel when the β1 subunit
is present, the exact binding site has not yet been identified. E2
activation can be induced when E2 is conjugated to a protein that
is impermeable to the membrane, but only when it is applied to
the outside of the cell, suggesting that the binding site is located in
the extracellular region of the β1 subunit (Valverde et al., 1999).
Regulation in proteasomal degradation of the β1 subunit in the
presence of E2 also suggests the importance of this subunit for
cellular metabolism (Korovkina et al., 2004; Nagar et al., 2005).
After identifying the stimulating activity of E2 on BK chan-
nel properties, research has focused on other molecules that can
exert the same characteristics. It has been shown that Tamoxifen
(Figure 7B), which is an agonist of estrogen receptors that is
widely used for breast cancer therapy, also activates the BK chan-
nel, but is at least 10 times more potent than E2, causing a
reversible and fast effect at concentrations as low as 0.1μM (Dick
et al., 2001). The E2-mediated increase in P0 was also observed
in the absence of cytoplasmic signals, as this effect was observed
in BK channels incorporated into lipid bilayers, as well as in out-
side out and inside out patches. Changes in channel activation,
however, were not seen when the BK α subunit was alone, as
confirmed in experiments with β1—knockout mice cells (Dick
and Sanders, 2001). Ethylbromide tamoxifen, which is a molecule
that does not permeate the membrane, was observed to elevate
potassium current at +40mV and also raise the open probabil-
ity when applied to the outside of the membrane, indicating that
there may be an extracellular binding site (Dick et al., 2002) just
as was proposed for E2 (Valverde et al., 1999).
Dehydroepiandrosterone (DHEA; Figure 7C), which is an
adrenal androgen, is another steroid derivative that activates BK
channels, for which such sensitivity is provided by the β2 subunit.
Corticoesterone (Figure 7D) at physiological concentrations can
also quickly and reversibly activate BK channels when expressed
with the β4 subunit. Under conditions of constant calcium con-
centration, it primarily acts by shifting the voltage activation
curve to the left. This finding has suggested that β subunits dif-
ferentiate between steroids, but that BK channels do not respond
when α subunits are present alone (King et al., 2006), which has
led to an increased interest in researching the molecules target-
ing the β1 subunit as a potential modulator of the BK channel.
Lithocholic acid (Figure 7E), being a cholane at micromolar con-
centrations (EC50 = 45μM), acts as a BK channel activator only
in channels formed by α + β1 (Bukiya et al., 2013).
The binding site of these molecules is another important
research focus, due to its pharmacological potential. Structural
molecular models and structure–activity relationship (SAR) stud-
ies have led to the identification of a binding site for lithocolic
acid in the β1 subunit TM2 domain (Bukiya et al., 2011). The
search for similarities in such models and structural databases is
FIGURE 7 | Chemical structure of steroids and other molecules that
modulate BK channel activity. (A) 17β-Estradiol. (B) Tamoxifen. (C)
Dehydroepiandrosterone. (D) Corticoesterone. (E) Lithocholic acid. (F)
Dehydrosoyasaponin-I. Using PyMOL Molecular Graphics System, Version
1.5.0.4 Schrödinger, LL. Gray, carbon atoms; white, hydrogen atoms; red,
oxygen atoms; blue, nitrogen atoms.
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helpful for the identification of other molecules, such as sodium
3-hydroxyolean-12-en-30-oate (HENA). This compound is not
a steroid, but it activates BK channels because it contains the
structural characteristics considered to be necessary for its acti-
vation and, interestingly, it also activates BK channels only when
β1 subunits are expressed (Bukiya et al., 2013).
Dehydrosoyasaponin-I (DHS-I) (Figure 7F) isolated from
Desmodium adscendens is a reversible and potent activator of the
BK channel. When applied to the intracellular side of the mem-
brane, it causes a shift in both calcium- and voltage-dependent
activation curves. It was identified because it inhibits ChTX bid-
ing to the channel in bovine tracheal smooth muscle membranes
(McManus et al., 1993). A triterpene glycoside was the first and
most potent activator to be identified at nanomolecular (100 nM)
concentrations, causing an 80mV lefward shift in V1/2 and an
increase in open probability by means of a direct mechanism
(Giangiacomo et al., 1998). The identification of this effect in
smooth muscle membranes has led to report that such activation
depends on the expression of the β1 subunit, although it is unclear
whether this effect is determined by other subunits as well (Bukiya
et al., 2012).
OTHER MOLECULES
Tungstate is a molecule commonly used as and antihypertensive
agent (Swei et al., 1999) that modulates BK channels express-
ing α subunits alone or coexpressed with β subunits (β1 –
β4) in a concentration-dependent manner (Fernández-Mariño
et al., 2012). When comparing 0.1 and 1mM of tungstate, it was
observed that both concentrations can induce a decrease in V1/2,
but reductions in current amplitude are seen only at higher con-
centrations. V1/2 declines are calcium-dependent and are only
seen in the presence of β1 or β4 subunits, but not in channels con-
taining β2 or β3 subunits (Fernández-Mariño et al., 2012). The
tungstate putative binding site is located in the BK channel α sub-
unit, but residues from the β1 extracellular loop are also required
for the appropriate activation of the channel. It has been proposed
that extracellular loop residues are involved in maintaining the
BK channel structure needed for tungstate to bind to the channel
(Fernández-Mariño et al., 2014).
Another BK channel activator is DiBAC4 (bis (1,3)-
dibutylbarbituric acid) trimethine oxonol), which is a
voltage-sensitive fluorescent dye that significantly increases
whole-cell BK α + β1 currents in HEK293 cells and in native
channels from urinary bladder smooth muscle cells. DiBAC4
shifts the activation voltage to hyperpolarizing potentials without
causing changes in single-channel conductance. Morimoto et al.
(2007) reported that DiBAC4 activates whole-cell rBKα + β1 and
rBKα + β4 currents partially blocking rBKα + β2 currents with
no effects on channels where the α subunit is alone (Morimoto
et al., 2007). Nonetheless, Scornik et al. (2013) suggested that
the DiBAC4 binding site should be in the α subunit, since
DiBAC4 selectively enhances BK channel activity in the presence
or absence of the β1 subunit (Scornik et al., 2013). It has been
shown that DiBAC4 can increase deactivation time constants
without changing the voltage dependence of deactivation.
Although the latter effects do not necessarily require the presence
of β1 subunits, these subunits enhance BK channel response
to DiBAC4. It has also been established that leftward shifts in
conductance-voltage curves induced by DiBAC4 are significantly
larger in channels expressing α + β1 than in those expressing
α subunits alone. Moreover, β1 subunits promote a four-fold
decrease in the Kd of DiBAC4. Such findings could envision a new
scope for the role β1 subunits in cardiovascular pharmacology
(Bosch et al., 2014).
Additionally, NO, being an endogenous vasodilatation gas, can
rapidly, reversibly, and significantly increase BK open channel
probability from both sides of the membrane (Bolotina et al.,
1994; Peng et al., 1996). Carbonmonoxide (CO), which is another
endogenous like NO, can increase native BK channel activity.
However, stimulatory effects of CO and NO rely on specific inter-
actions, where CO interacts with α and NO with β subunits (Wu
et al., 2002). The alkaloid tetrandine is a blocker of hslo current
and its action as a BK inhibitor is potentiated in channels coex-
pressing α and β subunits (Dworetzky et al., 1996). In endothelial
human cells, it was found that tetrandrine shifted the G-V to
more positive potentials and inhibited the maximal P0 (Wu et al.,
2000b). BK channel expression in human gliomas appears to be
correlated with tumor malignancy grade and is involved in the
proliferation of human osteoblasts (Henney et al., 2009; Chen and
Tseng, 2010).
CONCLUDING REMARKS
BK channels are related to different pathophysiological processes,
such as changes in vascular tone regulation, diabetes, kidney,
and nervous system diseases. The expression of auxiliary β sub-
units plays an important role in these processes because of the
modulatory effects of these subunits on BK channel activity,
inducing changes in their biophysical properties. Furthermore,
β subunits act like binding sites for various molecules that reg-
ulate BK channel activity, prompting an increase or decrease in
the effects induced by drugs. This knowledge would be impor-
tant in drug design, since it may be possible to find molecules
that induce specific modulatory effects on BK channel proper-
ties, depending on the tissue types where they are expressed.
That is particularly important in smooth muscles and in the ner-
vous system, where β1 and β4 are highly expressed and have
been found to significantly regulate the biophysical properties of
BK channels.
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